Biocatalysts Ltd successfully completes the acquisition of Breatec, WeissBioTech and Biosun from its parent company BRAIN Biotech AG, creating the Bioproducts division under the Biocatalysts brand.
Biocatalysts Ltd successfully completed the acquisition of Breatec, WeissBioTech and Biosun from its parent company BRAIN Biotech AG, creating the Bioproducts division under the Biocatalysts brand. The completion of these acquisitions enhances the ability to capitalise on synergies within the BRAIN group and intensifies focus on strong growth in our core European and North American markets.
As a multi-speciality enzyme business, Biocatalysts Ltd is well positioned to continue to drive profitable growth and expansion within the Food, Beverage, and Life Science industries. The focused application capability, scale-up and fermentation expertise within the group, combined with the benefits of shared services will further increase responsiveness to meet ever-changing industry needs and position Biocatalysts Ltd as the enzyme partner of choice. As a member of the BRAIN Group, we offer our partners best-in-class enzyme metagenome discovery as well as strain and protein-engineering capabilities.
Biocatalysts Ltd is already an established and well-respected supplier of enzyme products within the Dairy, Protein and Flavour industries, as well as a trusted scale up partner for novel enzymes within the Food and Pharmaceutical markets. With the additional expertise and excellent application knowledge from Breatec, WeissBioTech and Biosun, we will use our combined capabilities to further develop the Baking, Beverages and Grain Processing markets.’